Infant Bacterial Therapeutics AB (IBT B) - Financial and Strategic SWOT Analysis Review

  • ID: 4281548
  • SWOT Analysis
  • 25 pages
  • GlobalData
1 of 4
Summary

Infant Bacterial Therapeutics AB (IBT), a subsidiary of BioGaia AB is a pharmaceutical company which develops drugs influencing the human infant microbiome to treat rare diseases in premature infants. Its pipeline product candidates include IBP-9414, containing the active substance Lactobacillus reuteri, co-evolved human bacterial strain derived from human breast milk, used for the prevention of Necrotizing enterocolitis (NEC); and IBP-1016, a drug candidate used for the treatment of gastroschisis, a severe disease in infants. The company develops pharmaceutical drug candidates for gastrointestinal neonatal condition that causes mucosal injury, necrosis, perforation in the intestinal tracts of infants and death. It operates through a network of neonatologists and research groups. IBT is headquartered in Stockholm, Sweden.

Infant Bacterial Therapeutics AB Key Recent Developments

Feb 28, 2018: Infant Bacterial Therapeutics Interim Management Statement, January 1 - December 31, 2017
Jan 17, 2018: New Project Manager at IBT
Aug 28, 2017: Infant Bacterial Therapeutics: Interim Management Statement, January 1 - June 30, 2017
May 04, 2017: Infant Bacterial Therapeutics: Interim Management Statement, January 1 - March 31, 2017
Mar 10, 2017: InfantBacterial Therapeutics has been approved for listing on Nasdaq First North’s Premier segment

This comprehensive SWOT profile of Infant Bacterial Therapeutics AB provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Infant Bacterial Therapeutics AB including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
READ MORE
Note: Product cover images may vary from those shown
2 of 4
Section 1 - About the Company
  • Infant Bacterial Therapeutics AB - Key Information
  • Infant Bacterial Therapeutics AB - Overview
  • Infant Bacterial Therapeutics AB - Key Employees
  • Infant Bacterial Therapeutics AB - Key Employee Biographies
  • Infant Bacterial Therapeutics AB - Key Operational Heads
  • Infant Bacterial Therapeutics AB - Major Products and Services
  • Infant Bacterial Therapeutics AB - History
  • Infant Bacterial Therapeutics AB - Company Statement
  • Infant Bacterial Therapeutics AB - Locations And Subsidiaries
  • Infant Bacterial Therapeutics AB - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Infant Bacterial Therapeutics AB - Business Description
  • Infant Bacterial Therapeutics AB - Corporate Strategy
  • Infant Bacterial Therapeutics AB - SWOT Analysis
  • SWOT Analysis - Overview
  • Infant Bacterial Therapeutics AB - Strengths
  • Infant Bacterial Therapeutics AB - Weaknesses
  • Infant Bacterial Therapeutics AB - Opportunities
  • Infant Bacterial Therapeutics AB - Threats
  • Infant Bacterial Therapeutics AB - Key Competitors
Section 3 - Company Financial Performance Charts
  • Infant Bacterial Therapeutics AB - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • Infant Bacterial Therapeutics AB, Key Information
  • Infant Bacterial Therapeutics AB, Key Ratios
  • Infant Bacterial Therapeutics AB, Share Data
  • Infant Bacterial Therapeutics AB, Major Products and Services
  • Infant Bacterial Therapeutics AB, History
  • Infant Bacterial Therapeutics AB, Key Employees
  • Infant Bacterial Therapeutics AB, Key Employee Biographies
  • Infant Bacterial Therapeutics AB, Key Operational Heads
  • Infant Bacterial Therapeutics AB, Other Locations
  • Infant Bacterial Therapeutics AB, Subsidiaries
  • Infant Bacterial Therapeutics AB, Key Manufacturing facilities
  • Infant Bacterial Therapeutics AB, Key Competitors
  • Infant Bacterial Therapeutics AB, SWOT Analysis
  • Infant Bacterial Therapeutics AB, Ratios based on current share price
  • Infant Bacterial Therapeutics AB, Annual Ratios
  • Infant Bacterial Therapeutics AB, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Infant Bacterial Therapeutics AB, Performance Chart
  • Infant Bacterial Therapeutics AB, Ratio Charts
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll